Iovance Biotherapeutics Inc. Stock
Iovance Biotherapeutics Inc. took a tumble today and lost -€0.180 (-5.710%).
We see a rather positive sentiment for Iovance Biotherapeutics Inc. with 18 Buy predictions and 2 Sell predictions.
Based on the current price of 2.94 € the target price of 10 € shows a potential of 240.14% for Iovance Biotherapeutics Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Iovance Biotherapeutics Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Iovance Biotherapeutics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Iovance Biotherapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Iovance Biotherapeutics Inc. | -5.710% | -0.993% | -15.115% | 1.187% | 23.946% | -44.149% | -88.352% |
| Ligand Pharmaceuticals | 1.140% | 1.676% | -0.546% | 97.826% | 9.639% | 177.863% | 49.425% |
| United Therapeutics | 0.760% | 0.327% | 4.602% | 98.224% | 14.908% | 138.813% | 194.012% |
| Ionis Pharmaceuticals Inc. | 1.150% | -1.696% | 2.246% | 167.478% | -6.210% | 86.866% | 85.398% |
Comments
Iovance Biotherapeutics (IOVA) had its "buy" rating reaffirmed by Chardan Capital. They now have a $16.00 price target on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics (IOVA) had its price target raised by Barclays PLC from $10.00 to $11.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics (IOVA) had its price target lowered by Chardan Capital from $17.00 to $16.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IOVA provided by MarketBeat